Dabigatran is effective with a favourable safety profile in normal and overweight patients undergoing major orthopaedic surgery: a pooled analysis.
Thromb. Res., Nov;130(5):818-20 (2012)
Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials.
Thromb J., 10(1):9 (2012)
Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding.
Thromb. Haemost., Jul;108(1):183-90 (2012)
Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Thromb. Res., Aug;130(2):147-51 (2012)
Prevention of venous thromboembolism after hip or knee arthroplasty: findings from a 2008 survey of US orthopedic surgeons.
J Arthroplasty., May;27(5):659-66.e5 (2012)
Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Orthopedics., Oct;34(10):795-804 (2011)
Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.
Expert Rev Pharmacoecon Outcomes Res., Jun;11(3):299-306 (2011)
New oral anticoagulants for venous thromboembolism prophylaxis in orthopaedic surgery.
Instr Course Lect., 60:291-300 (2011)
Strengths and limitations of standards of care to guide the orthopedic surgeon in VTE prevention.
Orthopedics., Feb;34(2):121-8 (2011)
Lessons learned from the global orthopaedic registry: study design, current practice patterns, and future directions.
Am J. Orthop., Sep;39(9 Suppl):29-31 (2010)
Practice patterns in the use of venous thromboembolism prophylaxis after total joint arthroplasty--insights from the Multinational Global Orthopaedic Registry (GLORY).
Am J. Orthop., Sep;39(9 Suppl):14-21 (2010)
Oral dabigatran versus enoxaparin for thromboprophylaxis after primary total hip arthroplasty (RE-NOVATE II*). A randomised, double-blind, non-inferiority trial.
Thromb. Haemost., Apr;105(4):721-9 (2011)
Limit the bleeding, limit the pain in total hip and knee arthroplasty.
Orthopedics., Sep;33(9 Suppl):11-3 (2010)
Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials.
Thromb. Res., Sep;126(3):175-82 (2010)
New oral anticoagulants for thromboprophylaxis after total hip or knee arthroplasty.
Orthopedics., Dec;32(12 Suppl):79-84 (2009)
New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty.
Thrombosis., 2010:280731 (2010)
Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery.
Thrombosis., 2010:108049 (2010)
Dabigatran etexilate: pivotal trials for venous thromboembolism prophylaxis after hip or knee arthroplasty.
Clin. Appl. Thromb. Hemost., 15 Suppl 1:25S-31S (2009 Sep-Oct)
VTE prophylaxis after hip fracture surgery.
Am J. Orthop., Oct;37(10):502; discussion 502-9 (2008)
Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
N. Engl. J. Med., Jun;358(26):2765-75 (2008)